Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10784122.3Aexternal-prioritypatent/EP2438048B1/en
Application filed by Amira Pharmaceuticals, Inc.filedCriticalAmira Pharmaceuticals, Inc.
Publication of CY1115482T1publicationCriticalpatent/CY1115482T1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Στο παρόν κείμενο περιγράφονται ενώσεις οι οποίες είναι ανταγωνιστές υποδοχέων λυσοφωσφατιδικού οξέος. Επίσης περιγράφονται φαρμακευτικές συνθέσεις και φάρμακα που περιλαμβάνουν τις ενώσεις που περιγράφονται στο κείμενο, καθώς και μέθοδοι χρήσης τέτοιων ανταγωνιστών, μεμονωμένα και σε συνδυασμό με άλλες ενώσεις, για την αγωγή LPA-εξαρτώμενων ή LPA-μεσολαβούμενων καταστάσεων ή παθήσεων.Herein are described compounds which are lysophosphatidic acid receptor antagonists. Also described are pharmaceutical compositions and medicaments comprising the compounds described herein, as well as methods of using such antagonists, individually and in combination with other compounds, for the treatment of LPA-dependent or LPA-mediated conditions or diseases.
CY20141100205T2009-06-032014-03-14
POLYCYCLIC COMPOUNDS OF LYOSPHOSPHATIC ACID RECEPTOR COMPONENTS
CY1115482T1
(en)